What can the lived experience of participating in risky HIV cure-related studies establish?
This response to Gail Henderson et al argues that they were right that interviewees’ appraisals of cure study participation should inform (future) protocol review decisions, but wrong to take these appraisals at face value.
Main Author: | |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
BMJ Publ.
2018
|
In: |
Journal of medical ethics
Year: 2018, Volume: 44, Issue: 4, Pages: 277-278 |
Online Access: |
Presumably Free Access Volltext (JSTOR) Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
Summary: | This response to Gail Henderson et al argues that they were right that interviewees’ appraisals of cure study participation should inform (future) protocol review decisions, but wrong to take these appraisals at face value. |
---|---|
ISSN: | 1473-4257 |
Contains: | Enthalten in: Journal of medical ethics
|
Persistent identifiers: | DOI: 10.1136/medethics-2017-104593 |